Marilyn N. Martinez

发表

Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls

M. Papich, Marilyn N. Martinez, Marilyn N. Martinez, 2015, The AAPS Journal.

Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals.

P. McDermott, R. Walker, Marilyn Martinez, 2006, Veterinary journal.

Pharmacogenetic and Metabolic Differences Between Dog Breeds: Their Impact on Canine Medicine and the Use of the Dog as a Preclinical Animal Model

Marilyn N. Martinez, E. Ostrander, K. Mealey, 2008, The AAPS Journal.

Terminology challenges: defining modified release dosage forms in veterinary medicine.

S. Modrić, Marilyn N. Martinez, D. Lindquist, 2010, Journal of pharmaceutical sciences.

The Pharmacodynamics of Antimicrobial Agents

P. Toutain, J. Turnidge, Marilyn N. Martinez, 2013 .

Formulation and Design of Veterinary Tablets

R. Fahmy, Marilyn N. Martinez, D. Danielson, 2008 .

Considerations in the extrapolation of drug toxicity between humans and dogs

Marilyn N. Martinez, J. Mochel, D. Pade, 2020 .

In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.

Marilyn N. Martinez, D. Burgess, M. Rathbone, 2008, Journal of controlled release : official journal of the Controlled Release Society.

Primer on the Science of In Vitro Dissolution Testing of Oral Dosage Forms and Factors Influencing its Biological Relevance

R. Fahmy, Marilyn N. Martinez, Marilyn N. Martinez, 2019, Dissolution Technologies.

Antimicrobial drug resistance.

Marilyn N. Martinez, P. Silley, Marilyn N. Martinez, 2010, Handbook of experimental pharmacology.

AAPS/RAPS/CAPRA collaborative program: Exploring the challenges of drug regulation in a global environment: Clinical concerns

I. McGilveray, Marilyn N. Martinez, Marilyn N. Martinez, 2003, AAPS PharmSci.

A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

Gordon L Amidon, Marilyn N Martinez, G. Amidon, 2002, Journal of clinical pharmacology.

Bioavailability Bloequlvalence Assessments

Marilyn N. Martinez, M. Berson, Marilyn N. Martinez, 1998 .

Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?

Marilyn N. Martinez, L. Antonovic, Marilyn N. Martinez, 2011, Future medicinal chemistry.

Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process

N. Patel, M. Jamei, A. Rostami-Hodjegan, 2016, The AAPS Journal.

Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics

L. Trepanier, B. Kukanich, M. Dacasto, 2013, Drug metabolism reviews.

Effect of age on plasma protein binding of several veterinary drugs in dairy calves 2.

Jennifer L Davis, R. Baynes, Geof W. Smith, 2018, Research in veterinary science.

Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.

G. Amidon, A. Mitra, J. Riviere, 2002, Advanced drug delivery reviews.

The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

Anette Müllertz, Arzu Selen, Hans Lennernäs, 2014, Journal of pharmaceutical sciences.

Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

G. Drusano, M. Papich, Marilyn N. Martinez, 2012, Antimicrobial Agents and Chemotherapy.

Modified release drug delivery in veterinary medicine.

M. Rathbone, Marilyn N. Martinez, Marilyn N. Martinez, 2002, Drug discovery today.

Questions associated with the development of novel drugs intended for the treatment of bacterial infections in veterinary species.

J. Watts, J. Gilbert, Marilyn N. Martinez, 2019, Veterinary journal.

Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach

J. Mochel, E. Guillot, A. Jergens, 2021, Frontiers in Toxicology.

Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves

Jennifer L Davis, R. Baynes, Geof W. Smith, 2019, PloS one.

Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations.

L. Augsburger, T. Johnston, W. Jones, 2002, Advanced drug delivery reviews.

A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development

David J Brayden, D. Brayden, F. Kesisoglou, 2022, The AAPS Journal.

Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics

J. Mochel, D. Pade, S. Neuhoff, 2021, The AAPS Journal.

Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future Practitioners

R. Jelliffe, G. Drusano, Marilyn N. Martinez, 2022, The AAPS Journal.

Review of the 1993 Veterinary Drug Bioequivalence Workshop, held on March 29-31, 1993, in Rockville, Maryland.

J. Riviere, Marilyn N. Martinez, Marilyn N. Martinez, 1994, Journal of veterinary pharmacology and therapeutics.

Population variability in animal health: Influence on dose-exposure-response relationships: Part I: Drug metabolism and transporter systems.

Marilyn N. Martinez, J. Fink-Gremmels, K. Mealey, 2018, Journal of veterinary pharmacology and therapeutics.

Population variability in animal health: Influence on dose-exposure-response relationships: Part II: Modelling and simulation.

R. Gehring, J. Mochel, D. Pade, 2018, Journal of veterinary pharmacology and therapeutics.

Factors influencing the gastric residence of dosage forms in dogs.

M. Papich, Marilyn N. Martinez, Marilyn N. Martinez, 2009, Journal of pharmaceutical sciences.

Proposed method for estimating clinical cut-off (COCL) values: An attempt to address challenges encountered when setting clinical breakpoints for veterinary antimicrobial agents.

Marilyn N. Martinez, J. Turnidge, Marilyn N. Martinez, 2017, Veterinary journal.

Impact of ABCB1 genotype in Collies on the pharmacokinetics of R‐ and S‐fexofenadine

M. Myers, M. Sharkey, L. Troutman, 2018, Journal of veterinary pharmacology and therapeutics.

Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study

M. Myers, J. Qiu, M. Sharkey, 2015, Drug Metabolism and Disposition.

Influence of ABCB 1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study

M. Myers, J. Qiu, M. Sharkey, 2015 .

Regulatory Issues and Challenges Associated with the Development of Performance Specifications for Modified Release Parenteral Products

Marilyn N. Martinez, Mansoor A. Khan, M. Khan, 2012 .

Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls

M. Papich, Marilyn N. Martinez, Marilyn N. Martinez, 2015, The AAPS Journal.

A SAS/IML program for simulating pharmacokinetic data

Marilyn N. Martinez, Estelle Russek-Cohen, Anna B. Nevius, 2005, Comput. Methods Programs Biomed..

Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics

R. Fahmy, Marilyn N. Martinez, M. Papich, 2022, ADMET & DMPK.

Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.

M. Jamei, D. Pade, D. Turner, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin

R. Kona, R. Fahmy, J. Polli, 2016, The AAPS Journal.

A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption

K. Giacomini, E. Tsakalozou, E. Borbás, 2022, The AAPS Journal.

Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments

Celia N. Cruz, R. Fahmy, Naresh Pavurala, 2018, International journal of pharmaceutics.

Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid.

Talia Flanagan, Anette Müllertz, Filippos Kesisoglou, 2016, Journal of pharmaceutical sciences.

Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study

J. Mochel, A. Jergens, K. Allenspach, 2023, Cells.

A Simple Approach for Comparing the In Vitro Dissolution Profiles of Highly Variable Drug Products: a Proposal

Xiongce Zhao, Marilyn N. Martinez, Marilyn N. Martinez, 2018, The AAPS Journal.

Solubility Criteria for Veterinary Drugs

Mario A. González, A. Parr, J. Riviere, 2017 .

Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach

R. Tiwari, J. Qiu, Marilyn N. Martinez, 2016, The AAPS Journal.

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System.

J. Mochel, K. Allenspach, J. Kopper, 2022, Journal of visualized experiments : JoVE.

Urokinase-plasminogen-activator sensitive polymeric photosensitizer prodrugs: design, synthesis and in vitro evaluation

N. Lange, M. Campo, M. Zuluaga, 2009 .